Security key
69353Y103
PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP)
CUSIP: 69353Y103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 53,625,367
- Total 13F shares
- 39,023,873
- Share change
- -1,450,916
- Total reported value
- $58,153,846
- Put/Call ratio
- 57%
- Price per share
- $1.49
- Number of holders
- 73
- Value change
- -$2,416,795
- Number of buys
- 27
- Number of sells
- 51
Report period
Q3 2024
Institutions
73
Top holders
10
PMVP full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
PMV Pharmaceuticals, Inc. SEC filings
PMV Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 69353Y103
Recent filing periods:
Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
12%
|
6,475,291
|
$10,489,971 | — | 30 Jun 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
5.2%
|
2,804,782
|
$4,543,747 | — | 30 Jun 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
5.1%
|
2,708,408
|
$4,387,621 | — | 30 Jun 2024 | |
| Euclidean Capital LLC |
13F
3/4/5
|
Company · 10%+ Owner |
4.9%
|
2,627,643
|
$4,256,782 | — | 30 Jun 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.4%
|
2,345,361
|
$3,799,484 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.3%
|
2,282,090
|
$3,696,986 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3.9%
|
2,078,866
|
$3,365,000 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.2%
|
1,716,474
|
$2,780,688 | — | 30 Jun 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
2.4%
|
1,309,397
|
$2,121,223 | — | 30 Jun 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.4%
|
1,275,462
|
$2,066,248 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
1,162,193
|
$1,882,753 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.9%
|
1,019,628
|
$1,651,797 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
808,744
|
$1,310,165 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.5%
|
779,025
|
$1,262,020 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
758,740
|
$1,229,159 | — | 30 Jun 2024 | |
| PERSONAL CFO SOLUTIONS, LLC |
13F
|
Company |
1%
|
550,342
|
$891,554 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.96%
|
515,629
|
$835,319 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.92%
|
493,500
|
$799,470 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.89%
|
475,000
|
$769,500 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.87%
|
464,952
|
$753,223 | — | 30 Jun 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.82%
|
439,139
|
$711,405 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.8%
|
427,724
|
$693,076 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.72%
|
388,308
|
$629,059 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.7%
|
375,000
|
$607,500 | — | 30 Jun 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.67%
|
358,400
|
$580,608 | — | 30 Jun 2024 | |
| Acuitas Investments, LLC |
13F
|
Company |
0.66%
|
353,749
|
$573,073 | — | 30 Jun 2024 | |
| Aldebaran Capital, LLC |
13F
|
Company |
0.65%
|
351,243
|
$569,014 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
340,386
|
$551,425 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
323,710
|
$524,410 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.6%
|
322,024
|
$521,679 | — | 30 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.48%
|
260,028
|
$421,245 | — | 30 Jun 2024 | |
| M&T BANK CORP |
13F
|
Company |
0.48%
|
258,484
|
$418,372 | — | 30 Jun 2024 | |
| RBF Capital, LLC |
13F
|
Company |
0.47%
|
253,361
|
$410,445 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.37%
|
200,545
|
$324,883 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.33%
|
178,592
|
$289,319 | — | 30 Jun 2024 | |
| Shay Capital LLC |
13F
|
Company |
0.31%
|
165,400
|
$267,948 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.31%
|
164,046
|
$265,755 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.28%
|
147,542
|
$239,018 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.27%
|
145,737
|
$236,094 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
145,078
|
$235,026 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
139,900
|
$226,638 | — | 30 Jun 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
134,700
|
$218,214 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.24%
|
129,400
|
$209,628 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.23%
|
126,004
|
$204,182 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.22%
|
119,237
|
$193,163 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
118,917
|
$192,646 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.16%
|
86,617
|
$140,320 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
84,903
|
$137,543 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.14%
|
77,743
|
$126,000 | — | 30 Jun 2024 | |
| Centiva Capital, LP |
13F
|
Company |
0.14%
|
76,963
|
$124,680 | — | 30 Jun 2024 |
Institutional Holders of PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) as of Q3 2024
As of 30 Sep 2024,
PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,023,873 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, Sio Capital Management, LLC, Euclidean Capital LLC, ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, PFM Health Sciences, LP, BML Capital Management, LLC, and BlackRock, Inc..
This page lists
73
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
91
Q3 2024 holders
73
Holder diff
-18
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.